Milestone Pharmaceuticals Inc.

NasdaqGS:MIST 주식 보고서

시가총액: US$92.0m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Milestone Pharmaceuticals 관리

관리 기준 확인 3/4

Milestone Pharmaceuticals' CEO는 Joe Oliveto, Mar2017 에 임명되었습니다 의 임기는 7.25 년입니다. 총 연간 보상은 $ 1.98M, 30.4% 로 구성됩니다. 30.4% 급여 및 69.6% 보너스(회사 주식 및 옵션 포함). 는 $ 396.40K 가치에 해당하는 회사 주식의 0.43% 직접 소유합니다. 396.40K. 경영진과 이사회의 평균 재임 기간은 각각 4 년과 6 년입니다.

주요 정보

Joe Oliveto

최고 경영자

US$2.0m

총 보상

CEO 급여 비율30.4%
CEO 임기7.3yrs
CEO 소유권0.4%
경영진 평균 재임 기간4yrs
이사회 평균 재임 기간6yrs

최근 관리 업데이트

Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely

Jun 07
Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely

Recent updates

Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely

Jun 07
Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely

Is Milestone Pharmaceuticals (NASDAQ:MIST) A Risky Investment?

Sep 13
Is Milestone Pharmaceuticals (NASDAQ:MIST) A Risky Investment?

We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

Mar 07
We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

Oct 15
We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

We Think Milestone Pharmaceuticals (NASDAQ:MIST) Can Afford To Drive Business Growth

Jun 24
We Think Milestone Pharmaceuticals (NASDAQ:MIST) Can Afford To Drive Business Growth

We're Hopeful That Milestone Pharmaceuticals (NASDAQ:MIST) Will Use Its Cash Wisely

Feb 25
We're Hopeful That Milestone Pharmaceuticals (NASDAQ:MIST) Will Use Its Cash Wisely

We're Interested To See How Milestone Pharmaceuticals (NASDAQ:MIST) Uses Its Cash Hoard To Grow

Aug 25
We're Interested To See How Milestone Pharmaceuticals (NASDAQ:MIST) Uses Its Cash Hoard To Grow

Companies Like Milestone Pharmaceuticals (NASDAQ:MIST) Are In A Position To Invest In Growth

Apr 02
Companies Like Milestone Pharmaceuticals (NASDAQ:MIST) Are In A Position To Invest In Growth

What You Need To Know About Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Investor Composition

Jan 15
What You Need To Know About Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Investor Composition

First patient enrolled in Milestone Pharmaceuticals' late-stage study of etripamil in PSVT

Nov 18

Milestone Pharmaceuticals EPS beats by $0.09

Nov 13

CEO 보상 분석

Joe Oliveto 의 보수는 Milestone Pharmaceuticals 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$55m

Dec 31 2023US$2mUS$602k

-US$60m

Sep 30 2023n/an/a

-US$59m

Jun 30 2023n/an/a

-US$59m

Mar 31 2023n/an/a

-US$59m

Dec 31 2022US$3mUS$584k

-US$58m

Sep 30 2022n/an/a

-US$62m

Jun 30 2022n/an/a

-US$62m

Mar 31 2022n/an/a

-US$44m

Dec 31 2021US$4mUS$509k

-US$43m

Sep 30 2021n/an/a

-US$35m

Jun 30 2021n/an/a

-US$32m

Mar 31 2021n/an/a

-US$46m

Dec 31 2020US$4mUS$470k

-US$50m

Sep 30 2020n/an/a

-US$60m

Jun 30 2020n/an/a

-US$60m

Mar 31 2020n/an/a

-US$61m

Dec 31 2019US$785kUS$458k

-US$55m

Sep 30 2019n/an/a

-US$47m

Jun 30 2019n/an/a

-US$40m

Mar 31 2019n/an/a

-US$29m

Dec 31 2018US$1mUS$360k

-US$23m

Dec 31 2017US$851kUS$364k

-US$8m

보상 대 시장: Joe 의 총 보상 ($USD 1.98M )은 US 시장( $USD 683.56K ).

보상과 수익: Joe 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Joe Oliveto (56 yo)

7.3yrs

테뉴어

US$1,978,092

보상

Mr. Joseph G. Oliveto, also known as Joe, M.B.A. has been Chief Executive Officer and President of Milestone Pharmaceuticals Inc. March 2017 and has been its Director since July 2017. Mr. Oliveto served as...


리더십 팀

이름위치테뉴어보상소유권
Joseph Oliveto
CEO, President & Director7.3yrsUS$1.98m0.43%
$ 396.4k
Amit Hasija
CFO & Executive VP of Corporate Development4.8yrsUS$1.01m0.029%
$ 26.7k
David Bharucha
Chief Medical Officer2.3yrsUS$1.22m0.023%
$ 21.0k
Philippe Douville
Founderno data데이터 없음데이터 없음
Jeffrey Nelson
Chief Operating Officer4yrs데이터 없음데이터 없음
Kim Fox
Vice President of Communicationsless than a year데이터 없음데이터 없음
Philip Sager
Chief Medical Advisor & Member of the Scientific Advisory Board4.4yrs데이터 없음데이터 없음
Guy Rousseau
SVP of Regulatory Affairs and Quality Managementno data데이터 없음데이터 없음
Anita Holz
VP & Head of Medical Affairs1.8yrs데이터 없음데이터 없음

4.0yrs

평균 재임 기간

59yo

평균 연령

경험이 풍부한 관리: MIST 의 관리팀은 경험 ( 4 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Joseph Oliveto
CEO, President & Director6.9yrsUS$1.98m0.43%
$ 396.4k
Philippe Douville
Founder4.4yrs데이터 없음데이터 없음
Philip Sager
Chief Medical Advisor & Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Harry Leighton
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Daniel Omstead
Observer6.8yrs데이터 없음데이터 없음
Harry Kopelman
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Debra Liebert
Independent Non-Executive Director9yrsUS$149.27k0.015%
$ 14.1k
John DiMarco
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Paul Dorian
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Michael Tomsicek
Independent Non-Executive Director5.2yrsUS$153.27k0.023%
$ 20.8k
John Camm
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Robert Wills
Independent Chairman of the Board3.7yrsUS$176.77k0.023%
$ 20.8k

6.0yrs

평균 재임 기간

68yo

평균 연령

경험이 풍부한 이사회: MIST 의 이사회경험(평균 재직 기간 6 년)으로 간주됩니다.